Biomarkers in Heart Failure With Preserved Ejection Fraction: An Update on Progress and Future Challenges

Heart Lung and Circulation - United Kingdom
doi 10.1016/j.hlc.2019.05.180
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Biomarkers in Acutely Decompensated Heart Failure With Preserved or Reduced Ejection Fraction

American Heart Journal
Cardiovascular MedicineCardiology
2012English

Biomarkers, Myocardial Fibrosis and Co-Morbidities in Heart Failure With Preserved Ejection Fraction: An Overview

Archives of Medical Science
Medicine
2018English

Prognosis in Heart Failure With Preserved Ejection Fraction

sudan heart journal
2017English

Heart Failure With Preserved Ejection Fraction – Concept, Pathophysiology, Diagnosis and Challenges for Treatment

Open Access Macedonian Journal of Medical Sciences
Medicine
2015English

Microvascular Rarefaction and Heart Failure With Preserved Ejection Fraction

Frontiers in Cardiovascular Medicine
Cardiovascular MedicineCardiology
2019English

Spironolactone for Heart Failure With Preserved Ejection Fraction

New England Journal of Medicine
Medicine
2014English

Influence of Ejection Fraction on Cause-Specific Mortality in Heart Failure With Preserved Ejection Fraction

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2017English

Prognosis of Heart Failure With Stable Mid-Range Ejection Fraction in Comparison to Heart Failure With Stable Reduced Ejection Fraction and Heart Failure With Stable Preserved Ejection Fraction

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Biomarkers and Prognostication in Heart Failure With Reduced and Preserved Ejection Fraction: Similar but Different?

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy